In Brief: Hoechst Marion Roussel Anzemet
Executive Summary
Hoechst Marion Roussel Anzemet: Dolasetron mesylate injection (NDA 20-624) "approvable" Feb. 20 for the prevention of nausea and vomiting associated with emetogenic cancer chemotherapy for initial and repeat courses...